Neoadjuvant SHR-A1811 Plus Adebrelimab in HR Negative/Low & HER2 Low Breast Cancer Patients

Clinical trial NCT06592625 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06592625
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Untreated Early-stage or Locally Advanced Breast Cancer

Start date: 2024-09-20
Primary completion: 2026-02-28
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.